AIG
FOLD

American International Group’s Amicus Therapeutics FOLD Stock Holding History

American International Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-143,034
Closed -$1.68M – 1007
2024
Q1 		$1.68M Buy
143,034
+1,785
+1% +$22.8K 0.01% 1069
2023
Q4 		$2M Buy
141,249
+1,298
+0.9% +$14.7K 0.01% 994
2023
Q3 		$1.7M Buy
139,951
+4,976
+4% +$64.2K 0.01% 1003
2023
Q2 		$1.7M Buy
134,975
+1,872
+1% +$22.2K 0.01% 1014
2023
Q1 		$1.48M Buy
133,103
+2,649
+2% +$32.7K 0.01% 1043
2022
Q4 		$1.59M Sell
130,454
-475
-0.4% -$5.35K 0.01% 1017
2022
Q3 		$1.37M Buy
130,929
+1,850
+1% +$20.6K 0.01% 1059
2022
Q2 		$1.39M Sell
129,079
-1,484
-1% -$12.2K 0.01% 1071
2022
Q1 		$1.24M Sell
130,563
-9,191
-7% -$86.2K 0.01% 1217
2021
Q4 		$1.61M Sell
139,754
-4,180
-3% -$46.6K 0.01% 1170
2021
Q3 		$1.38M Sell
143,934
-3,421
-2% -$35K 0.01% 1247
2021
Q2 		$1.42K Sell
147,355
-10,488
-7% -$102K ﹤0.01% 1320
2021
Q1 		$1.56K Sell
157,843
-662
-0.4% -$10.2K 0.01% 1246
2020
Q4 		$3.66K Buy
158,505
+6,461
+4% +$132K 0.01% 889
2020
Q3 		$2.15M Sell
152,044
-3,458
-2% -$50.4K 0.01% 937
2020
Q2 		$2.35M Buy
155,502
+4,032
+3% +$49.1K 0.01% 904
2020
Q1 		$1.4M Sell
151,470
-8,752
-5% -$83.2K 0.01% 989
2019
Q4 		$1.56M Sell
160,222
-1,349
-0.8% -$12.3K 0.01% 1111
2019
Q3 		$1.3M Buy
161,571
+14,323
+10% +$155K 0.01% 1157
2019
Q2 		$1.84M Buy
147,248
+26,536
+22% +$337K 0.01% 1033
2019
Q1 		$1.64M Sell
120,712
-3,914
-3% -$47.8K 0.01% 1087
2018
Q4 		$1.19M Sell
124,626
-958
-0.8% -$10.5K ﹤0.01% 1179
2018
Q3 		$1.52M Buy
125,584
+2,264
+2% +$31.7K 0.01% 1187
2018
Q2 		$1.93M Buy
123,320
+4,153
+3% +$62.8K 0.01% 1036
2018
Q1 		$1.79M Buy
119,167
+6,684
+6% +$102K 0.01% 1014
2017
Q4 		$1.62M Buy
112,483
+2,855
+3% +$39.2K 0.01% 1104
2017
Q3 		$1.65M Buy
109,628
+20,597
+23% +$272K 0.01% 1064
2017
Q2 		$897K Buy
89,031
+2,819
+3% +$22.7K ﹤0.01% 1350
2017
Q1 		$615K Buy
86,212
+12,979
+18% +$82.1K ﹤0.01% 1464
2016
Q4 		$364K Sell
73,233
-189
-0.3% -$1.31K ﹤0.01% 1837
2016
Q3 		$543K Buy
73,422
+112
+0.2% +$757 ﹤0.01% 1565
2016
Q2 		$400K Buy
73,310
+6,177
+9% +$43.2K ﹤0.01% 1717
2016
Q1 		$567K Buy
67,133
+10,260
+18% +$72.7K ﹤0.01% 1916
2015
Q4 		$552K Sell
56,873
-398
-0.7% -$3.59K ﹤0.01% 1956
2015
Q3 		$801K Buy
57,271
+767
+1% +$12K ﹤0.01% 1622
2015
Q2 		$800K Buy
56,504
+55,504
+5,550% +$667K ﹤0.01% 1769
2015
Q1 		$10.9K Buy
+1,000
New +$8.81K ﹤0.01% 4512
2014
Q2 		– Sell
-20,672
Closed -$42.8K – 4984
2014
Q1 		$42.8K Buy
20,672
+496
+2% +$1.24K ﹤0.01% 3899
2013
Q4 		$47.4K Sell
20,176
-202
-1% -$443 ﹤0.01% 3796
2013
Q3 		$47.3K Sell
20,378
-384
-2% -$964 ﹤0.01% 3755
2013
Q2 		$48.4K Buy
+20,762
New +$63.8K ﹤0.01% 3586

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

American International Group's FOLD Position: Q2 2024 in Review

American International Group sold out of Amicus Therapeutics (FOLD) in Q2 2024, closing a stake of 143,034 shares — an estimated $1.68M sold.

American International Group first reported a position in FOLD in Q2 2013 and held it in 41 quarters. The position peaked at $2.35M in Q2 2020. 258 funds tracked by Wall St. Rank hold FOLD as of Q2 2024.

  • American International Group reported no remaining Amicus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 143,034 Amicus Therapeutics shares in Q2 2024, an estimated $1.68M.
  • American International Group first reported a position in Amicus Therapeutics in Q2 2013 and held it in 41 quarters.
  • American International Group's Amicus Therapeutics position peaked at $2.35M in Q2 2020.
  • 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.